product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Pit1 Antibody - BSA Free
catalog :
NBP1-92273
quantity :
0.1 ml (also 25 ul)
price :
559 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section
more info or order :
citations: 16
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; mouse; fig 3e
Duan S, Sawyer T, Sontz R, Wieland B, Diaz A, Merchant J. GFAP-directed Inactivation of Men1 Exploits Glial Cell Plasticity in Favor of Neuroendocrine Reprogramming. Cell Mol Gastroenterol Hepatol. 2022;14:1025-1051 pubmed publisher
Chiloiro S, Moroni R, Giampietro A, Angelini F, Gessi M, Lauretti L, et al. The Multibiomarker Acro-TIME Score Predicts fg-SRLs Response: Preliminary Results of a Retrospective Acromegaly Cohort. J Clin Endocrinol Metab. 2024;109:1341-1350 pubmed publisher
Hong S, Kim S, Lim S, Lee E, Kim S, Ku C, et al. Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience. Front Oncol. 2021;11:739290 pubmed publisher
Tjörnstrand A, Casar Borota O, Heurling K, Scholl M, Gjertsson P, Ragnarsson O, et al. Pre- and postoperative 68 Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumours. Clin Endocrinol (Oxf). 2021;: pubmed publisher
Taniguchi Ponciano K, Peña Martínez E, Silva Román G, Vela Patiño S, Guzmán Ortiz A, Quezada H, et al. Proteomic and Transcriptomic Analysis Identify Spliceosome as a Significant Component of the Molecular Machinery in the Pituitary Tumors Derived from POU1F1- and NR5A1-Cell Lineages. Genes (Basel). 2020;11: pubmed publisher
Taniguchi Ponciano K, Andonegui Elguera S, Peña Martínez E, Silva Román G, Vela Patiño S, Gómez Apo E, et al. Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep. 2020;10:19373 pubmed publisher
Casar Borota O, Boldt H, Engström B, Andersen M, Baussart B, Bengtsson D, et al. Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations. J Clin Endocrinol Metab. 2021;106:1183-1194 pubmed publisher
Abboud D, Daly A, Dupuis N, Bahri M, Inoue A, Chevigné A, et al. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11. Nat Commun. 2020;11:4752 pubmed publisher
Neou M, Villa C, Armignacco R, Jouinot A, Raffin Sanson M, Septier A, et al. Pangenomic Classification of Pituitary Neuroendocrine Tumors. Cancer Cell. 2020;37:123-134.e5 pubmed publisher
Tjörnstrand A, Casar Borota O, Heurling K, Scholl M, Gjertsson P, Himmelman J, et al. Lower 68 Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland-A proof-of-concept study. Clin Endocrinol (Oxf). 2020;92:222-231 pubmed publisher
Căpraru O, Gaillard C, Vasiljevic A, Lasolle H, Borson Chazot F, Raverot V, et al. Diagnosis, pathology, and management of TSH-secreting pituitary tumors. A single-center retrospective study of 20 patients from 1981 to 2014. Ann Endocrinol (Paris). 2019;80:216-224 pubmed publisher
Németh K, Darvasi O, Liko I, Szucs N, Czirjak S, Reiniger L, et al. Comprehensive analysis of circulating microRNAs in plasma of patients with pituitary adenomas. J Clin Endocrinol Metab. 2019;: pubmed publisher
Scaroni C, Albiger N, Daniele A, Dassie F, Romualdi C, Vazza G, et al. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly. J Clin Endocrinol Metab. 2019;104:856-862 pubmed publisher
Maher M, Roncaroli F, Mendoza N, Meeran K, Canham N, Kosicka Slawinska M, et al. A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma. Endocrinol Diabetes Metab Case Rep. 2018;2018: pubmed publisher
Albuquerque R, Carbonara C, Martin R, dos Reis L, do Nascimento C, Arap S, et al. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism. Surgery. 2018;163:381-387 pubmed publisher
Øystese K, Zucknick M, Casar Borota O, Ringstad G, Bollerslev J. Early postoperative growth in non-functioning pituitary adenomas; A tool to tailor safe follow-up. Endocrine. 2017;57:35-45 pubmed publisher
product information
master code :
NBP1-92273
SKU :
NBP1-92273
product name :
Pit1 Antibody - BSA Free
unit size :
0.1 ml (also 25 ul)
description :
The Pit1 Antibody - BSA Free from Novus is a rabbit polyclonal antibody to Pit1. This antibody reacts with human,mouse. The Pit1 Antibody - BSA Free has been validated for the following applications: IF/IHC,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry.
target :
Pit1
category :
Primary Antibodies
buffer :
PBS (pH 7.2) and 40% Glycerol
clonality :
Polyclonal
conjugate :
Unconjugated
host :
Rabbit
immunogen :
CKLKAILSKWLEEAEQVGALYNEKVGANERKRKRRTTIS
IAAKDALERHFGEQNKPSSQEIMRMAE
This antibody was developed against Recombinant Protein corresponding to amino acids:
isotype :
IgG
purity :
Immunogen affinity purified
species :
Human,Mouse
gene symbol :
POU1F1
Antibody validation :
Independent Anitbodies
applications :
IF/IHC,Western Blot,Immunohistochemistry-Paraffin,Immunocytochemistry/ Immunofluorescence,Immunohistochemistry
USD :
559 USD
alt names :
CPHD1, GHF1, GHF-1pituitary-specific positive transcription factor 1, Growth hormone factor 1, PIT-1, PIT1pituitary-specific transcription factor 1, POU class 1 homeobox 1, POU domain class 1, transcription factor 1, POU domain, class 1, transcription factor 1, POU1F1a
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.